No abstract available
Keywords:
adverse drug events; antiplatelet drugs; ischemic heart disease; pharmacogenetics; polymorphism; precision medicine.
MeSH terms
-
Acute Coronary Syndrome*
-
Cytochrome P-450 CYP3A
-
Hemorrhage / chemically induced
-
Humans
-
Percutaneous Coronary Intervention*
-
Platelet Aggregation Inhibitors / adverse effects
-
Ticagrelor / adverse effects
-
Treatment Outcome
Substances
-
Ticagrelor
-
Cytochrome P-450 CYP3A
-
Platelet Aggregation Inhibitors
-
CYP3A4 protein, human